C Thauvin-Eliopoulos

Author

Deaconess Hospital

Also Known As

C Thauvin-Eliopoulos, C. Thauvin-Eliopoulos, Claudie Thauvin-Eliopoulos, Claudie Thauvin‐Eliopoulos

Publications

860

Citations

H-Index

Concepts

All Affiliations

Deaconess Hospital Harvard University Beth Israel Deaconess Medical Center Deaconess Hospital

About

C Thauvin-Eliopoulos is an author at Deaconess Hospital specializing in infection control, drug resistance, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	6	6	499
2	Medicine	6	6	499
3	Microbiology	5	5	447
4	Pharmacology	5	5	407
5	Pathology	1	1	92

C Thauvin-Eliopoulos

Publications

823

Citations

H-Index

Page 1

	Year	Citations
Induction of Daptomycin Heterogeneous Susceptibility in <i>Staphylococcus aureus</i> by Exposure to Vancomycin George Sakoulas, Jeff Alder, C Thauvin-Eliopoulos, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug ResistanceInfection Control	2006	261
A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci Howard S. Gold, Serhat Ünal, Emilia Cercenado, Antimicrobial Agents and Chemotherapy Vanc GenesEnterococcus FaecalisAntimicrobial SusceptibilityHealth SciencesAntibiotics	1993	92
Activities of Taurolidine In Vitro and in Experimental Enterococcal Endocarditis Carlos Torres‐Viera, C Thauvin-Eliopoulos, Maria Souli, Antimicrobial Agents and Chemotherapy	2000	79
Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae C Thauvin-Eliopoulos, M. Tripodi, Robert C. Moellering, Antimicrobial Agents and Chemotherapy	1997	71
A Cluster of VanD Vancomycin‐Resistant<i>Enterococcus faecium:</i>Molecular Characterization and Clinical Epidemiology Belinda Ostrowsky, Nancye C. Clark, C Thauvin-Eliopoulos, The Journal of Infectious Diseases	1999	56
Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis M. Lindsay Grayson, C Thauvin-Eliopoulos, George M. Eliopoulos, Antimicrobial Agents and Chemotherapy Experimental Enterococcal EndocarditisTmp-smx-treated RatsActive DrugHealth SciencesAntibiotics	1990	52
Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus Athanasios Tsakris, Satish K. Pillai, Howard S. Gold, Journal of Antimicrobial Chemotherapy	2007	43
Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus C Thauvin-Eliopoulos, Louis B. Rice, George M. Eliopoulos, Antimicrobial Agents and Chemotherapy Antibiotic ResistanceRat ModelDrug ResistanceBeta-lactamase-hyperproducing Staphylococcus AureusSepsis	1990	39
Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin Joseph D. Yao, C Thauvin-Eliopoulos, George M. Eliopoulos, Antimicrobial Agents and Chemotherapy Antimicrobial ChemotherapyAntibiotic ResistanceRat ModelDrug ResistanceAntimicrobial Therapy	1990	30
Contribution of Animal Models in the Search for Effective Therapy for Endocarditis Due to Enterococci with High-Level Resistance to Gentamicin George M. Eliopoulos, C Thauvin-Eliopoulos, R C Moellering Clinical Infectious Diseases Sterile ValvesAntimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceAnimal Models	1992	25

Page 1